The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)-[1,2,3]triazolo[1,5-a]pyridine-3-carboxamide
ID: ALA1078239
PubChem CID: 46882663
Max Phase: Preclinical
Molecular Formula: C13H9ClN4O
Molecular Weight: 272.70
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1nnn2ccccc12
Standard InChI: InChI=1S/C13H9ClN4O/c14-9-5-1-2-6-10(9)15-13(19)12-11-7-3-4-8-18(11)17-16-12/h1-8H,(H,15,19)
Standard InChI Key: SGZJTQVMZSIZMJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-5.3893 -14.6801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3905 -15.5076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6756 -15.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6774 -14.2674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9620 -14.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9572 -15.5030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1696 -15.7539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6876 -15.0823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1774 -14.4166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1604 -13.5934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4385 -13.1940 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8673 -13.1680 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8523 -12.3430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1257 -11.9470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1104 -11.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8157 -10.7037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5422 -11.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5540 -11.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2746 -12.3250 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 5 2 0
4 1 2 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 2 0
17 18 2 0
18 13 1 0
8 9 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.70 | Molecular Weight (Monoisotopic): 272.0465 | AlogP: 2.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 59.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.57 | CX Basic pKa: ┄ | CX LogP: 3.20 | CX LogD: 3.20 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.78 | Np Likeness Score: -2.29 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |